50 Participants Needed

Acceptance and Commitment Therapy for Chronic Pain

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Colorado, Denver
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

A study to help manage chronic pain in cancer survivors through Acceptance and Commitment Therapy (ACT) after undergoing active cancer treatment, such as surgery, chemotherapy, and/or radiation.

Research Team

EK

Elissa Kolva, PhD

Principal Investigator

University of Colorado, Denver

Eligibility Criteria

This trial is for cancer survivors aged 18-100 who've been out of active treatment for at least three months, speak English, and are mentally stable. They should have had solid tumor cancers, be free of or have stable chronic disease, and experience moderate to severe pain from their cancer that's lasted over three months.

Inclusion Criteria

My cancer-related pain is moderate to severe, scoring 4 or higher.
Stated willingness to comply with all study procedures and be available for the duration of the study
Provision to sign and date the consent form
See 6 more

Exclusion Criteria

You have difficulties being part of a group because of things like feeling very nervous in social situations, or being in a group would make it harder for you to get the care you need.
My pain is not caused by my cancer.
I have been diagnosed with a brain or central nervous system cancer.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Acceptance and Commitment Therapy (ACT) and medication management for chronic pain

8 weeks
Weekly sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 weeks

Treatment Details

Interventions

  • Acceptance and Commitment Therapy
Trial Overview The study tests Acceptance and Commitment Therapy (ACT) as a way to manage chronic pain in cancer survivors against the usual treatments they receive. Participants will either receive ACT sessions or continue with their regular care to see which helps more with pain.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Acceptance and Commitment TherapyExperimental Treatment1 Intervention
Participants will receive both the ACT intervention and medication management that is given as usual treatment.
Group II: Treatment as UsualActive Control1 Intervention
Treatment as usual will include ongoing provision of usual treatment options for pain management.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials
1,842
Recruited
3,028,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security